Literature DB >> 29687165

Mechanism Underlying the Effects of Estrogen Deficiency on Otoconia.

Liping Yang1,2, Yinfang Xu1, Yan Zhang1, Sarath Vijayakumar3, Sherri M Jones3, Yunxia Yesha Wang Lundberg4.   

Abstract

Otoconia-related vertigo and balance deficits, particularly benign paroxysmal positional vertigo (BPPV), are common. Our recent studies in humans show that, while BPPV prevalence greatly increases with age in both genders, peri-menopausal women are especially susceptible. In the present study, we show that bilateral ovariectomized (OVX) mice have significant balance behavioral deficits, and that estrogen deficiency compromises otoconia maintenance and anchoring by reducing the expression of otoconial component and anchoring proteins. There is ectopic debris formation in the ampulla under estrogen deficiency due to aberrant matrix protein expression. Furthermore, phytoestrogen is effective in rescuing the otoconia abnormalities. By comparing the expression levels of known estrogen receptor (Esr) subtypes, and by examining the otoconia phenotypes of null mice for selected receptors, we postulate that Esr2 may be critical in mediating the effects of estrogen in otoconia maintenance.

Entities:  

Keywords:  BPPV; estrogen deficiency; estrogen receptor; menopause; otoconia; phytoestrogen

Mesh:

Substances:

Year:  2018        PMID: 29687165      PMCID: PMC6081893          DOI: 10.1007/s10162-018-0666-8

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  51 in total

Review 1.  Benign paroxysmal positional vertigo: Diagnostic criteria.

Authors:  Michael von Brevern; Pierre Bertholon; Thomas Brandt; Terry Fife; Takao Imai; Daniele Nuti; David Newman-Toker
Journal:  J Vestib Res       Date:  2015       Impact factor: 2.435

Review 2.  Estrogen-related receptor alpha as a therapeutic target in cancer.

Authors:  R A Stein; D P McDonnell
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

3.  Toward a systems biology of mouse inner ear organogenesis: gene expression pathways, patterns and network analysis.

Authors:  Samin A Sajan; Mark E Warchol; Michael Lovett
Journal:  Genetics       Date:  2007-07-29       Impact factor: 4.562

4.  Atomic force microscope observations of otoconia in the newt.

Authors:  R Hallworth; M L Wiederhold; J B Campbell; P S Steyger
Journal:  Hear Res       Date:  1995-05       Impact factor: 3.208

5.  Microprobe analysis of human otoconia.

Authors:  M Anniko; J Ylikoski; R Wróblewski
Journal:  Acta Otolaryngol       Date:  1984 Mar-Apr       Impact factor: 1.494

6.  Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta.

Authors:  J M Vanacker; K Pettersson; J A Gustafsson; V Laudet
Journal:  EMBO J       Date:  1999-08-02       Impact factor: 11.598

7.  Epidemiology of benign paroxysmal positional vertigo: a population based study.

Authors:  M von Brevern; A Radtke; F Lezius; M Feldmann; T Ziese; T Lempert; H Neuhauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

Review 8.  The aetiology of dizziness and how to examine a dizzy patient.

Authors:  M Ojala; J Palo
Journal:  Ann Med       Date:  1991-08       Impact factor: 4.709

9.  Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.

Authors:  Rob W J Collin; Ersan Kalay; Muhammad Tariq; Theo Peters; Bert van der Zwaag; Hanka Venselaar; Jaap Oostrik; Kwanghyuk Lee; Zubair M Ahmed; Refik Caylan; Yun Li; Henk A Spierenburg; Erol Eyupoglu; Angelien Heister; Saima Riazuddin; Elif Bahat; Muhammad Ansar; Selcuk Arslan; Bernd Wollnik; Han G Brunner; Cor W R J Cremers; Ahmet Karaguzel; Wasim Ahmad; Frans P M Cremers; Gert Vriend; Thomas B Friedman; Sheikh Riazuddin; Suzanne M Leal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

10.  Impaired body balance, fine motor function and hearing in women with Turner syndrome.

Authors:  Mostafa El-Mansoury; Marie-Louise Barrenäs; Inger Bryman; Charles Hanson; Kerstin Landin-Wilhelmsen
Journal:  Clin Endocrinol (Oxf)       Date:  2008-11-09       Impact factor: 3.478

View more
  8 in total

Review 1.  Auditory function and dysfunction: estrogen makes a difference.

Authors:  Amandine Delhez; Philippe Lefebvre; Christel Péqueux; Brigitte Malgrange; Laurence Delacroix
Journal:  Cell Mol Life Sci       Date:  2019-09-14       Impact factor: 9.261

2.  Otopetrin-2 Immunolocalization in the Human Macula Utricle.

Authors:  Ivan A Lopez; Gail Ishiyama; Dora Acuna; Akira Ishiyama
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-06       Impact factor: 1.547

3.  Association of Serum Calcium and Vitamin D with Benign Paroxysmal Positional Vertigo.

Authors:  Ron Jacob Thomas; M K Goutham; Vadisha Srinivas Bhat; Shrinath D Kamath; Rajeshwary Aroor; Satheesh Kumar Bhandary
Journal:  Int Arch Otorhinolaryngol       Date:  2021-11-03

4.  Hormones and Vestibular Disorders: The Quest for Biomarkers.

Authors:  Rhizlane El Khiati; Brahim Tighilet; Stephane Besnard; Christian Chabbert
Journal:  Brain Sci       Date:  2022-05-02

5.  Dizziness in peri- and postmenopausal women is associated with anxiety: a cross-sectional study.

Authors:  Masakazu Terauchi; Tamami Odai; Asuka Hirose; Kiyoko Kato; Mihoko Akiyoshi; Mikako Masuda; Reiko Tsunoda; Hiroaki Fushiki; Naoyuki Miyasaka
Journal:  Biopsychosoc Med       Date:  2018-12-12

6.  Assessment of Bone Metabolism in Male Patients With Benign Paroxysmal Positional Vertigo.

Authors:  Yunqin Wu; Zhenyi Fan; Hang Jin; Qiongfeng Guan; Min Zhou; Xiaoxiong Lu; Li Li; Wang Yan; Chengyao Gu; Caijing Chen; Weiwei Han
Journal:  Front Neurol       Date:  2018-09-05       Impact factor: 4.003

Review 7.  Advances in otolith-related protein research.

Authors:  Shouju Huang; Shuxia Qian
Journal:  Front Neurosci       Date:  2022-07-26       Impact factor: 5.152

8.  Review of the pathology underlying benign paroxysmal positional vertigo.

Authors:  Sertac Yetiser
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.